Tech Company Financing Transactions
TransPharma Medical Funding Round
TransPharma Medical closed a $18 million Series C funding round on 7/24/2006. Backers included Biomedical Investments, Evergreen Partners and Pitango Venture Capital.
Transaction Overview
Company Name
Announced On
7/24/2006
Transaction Type
Venture Equity
Amount
$18,000,000
Round
Series C
Investors
Proceeds Purpose
TransPharma will use the funds to progress its lead project, transdermal hPTH (1-34), into advanced clinical trials. Earlier this year, the Company announced promising human clinical results demonstrating efficient and effective transdermal delivery of hPTH (1-34) for the treatment of osteoporosis.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
2 Yodfat St. Northern Ind. Zone
Lod, 71291
Israel
Lod, 71291
Israel
Phone
Website
Email Address
Overview
TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daphna Heffetz
Chief Operating Officer
Yael Kenan
VP - Bus. Development
Judith Kornfeld
VP - Engineering
Giora Arbel
VP - Finance
Ronit Nahary
VP - R & D
Galit Levin
VP - R & D
Zev Sohn
VP - Regulatory Affairs
Hana Gadassi
Browse more venture capital transactions:
Prev: 7/24/2006: Kythera Biopharmaceuticals venture capital transaction
Next: 7/24/2006: SEQUANS Communications venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC transactions reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs